| |
The Fibromyalgia Impact Questionnaire (FIQ) was developed
in the late 1980s by Drs Burckhardt CS, Clark SR, Bennett RM at Oregon
Health & Science University, in an attempt to capture the total spectrum
of problems related to fibromyalgia and the responses to therapy. It was
first published in 1991 and since that time has been extensively used as
an index of therapeutic efficacy. The original questionnaire was
modified in 1997 and 2002, to reflect ongoing experience with the
instrument and to clarify the scoring
system. It is scored
from 0 to 100 with the latter number being the worst case. The average
score for fibromyalgia patients seen in tertiary care settings is about 55.
The FIQ is
widely used to assess change in fibromyalgia status and has been
translated into 13 languages:
Czech (Czech Republic), Dutch (The Netherlands), French (France,
Canada), German (Germany), Hebrew (Israel), Italian (Italy), Korean
(Korea), Polish (Poland), Romanian (Romania), Spanish (Argentina,
Spain), Swedish (Sweden), Turkish (Turkey).
Academic and Clinical Use
The FIQ is free for academic and clinical
use . You may obtain an on-line license to use the FIQ
by registering at
Academic and
Clinical License.
Commercial Use
The
FIQ is licensed by the Mapi Research Trust on behalf of the
copyright holders.
If you wish to use
the FIQ in commercial ventures, or obtain a translated version of the
FIQ, please contact Mapi Research Trust:
trust@mapi.fr
FIQ
Translations
If
you wish to obtain translated versions of the FIQ, please contact Mapi
Research Trust:
trust@mapi.fr
FIQ
(version 2.0 in pdf format)
Scoring for FIQ
(version 2.0)
A list of FIQ
References with
Abstracts
A review of the FIQ and its
development (Bennett)
An
historical and methodological overview of the FIQ (Burckhardt) |
|
